Page last updated: 2024-09-03

cp 115953 and pd-117596

cp 115953 has been researched along with pd-117596 in 1 studies

Compound Research Comparison

Studies (cp 115953)	Trials (cp 115953)	Recent Studies (post-2010) (cp 115953)	Studies (pd-117596)	Trials (pd-117596)	Recent Studies (post-2010) (pd-117596)
20	0	0	21	0	0

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aldous, SC; Coughlin, SA; Dorff, PH; Gruett, MD; Lesher, GY; Rake, JB; Reuman, M; Singh, B; Wentland, MP	1

Other Studies

1 other study(ies) available for cp 115953 and pd-117596

Article	Year
Mammalian topoisomerase II inhibitory activity of 1-cyclopropyl-6,8- difluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-oxo-3-quinolinecarb oxylic acid and related derivatives. Journal of medicinal chemistry, 1993, Sep-17, Volume: 36, Issue:19 Topics: Animals; Anti-Infective Agents; Fluoroquinolones; HeLa Cells; Humans; Leukemia P388; Mice; Quinolones; Structure-Activity Relationship; Topoisomerase II Inhibitors	1993

Article

Year

Mammalian topoisomerase II inhibitory activity of 1-cyclopropyl-6,8- difluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-oxo-3-quinolinecarb oxylic acid and related derivatives.

Journal of medicinal chemistry, 1993, Sep-17, Volume: 36, Issue:19

Topics: Animals; Anti-Infective Agents; Fluoroquinolones; HeLa Cells; Humans; Leukemia P388; Mice; Quinolones; Structure-Activity Relationship; Topoisomerase II Inhibitors

1993